Cystic Fibrosis Foundation sells drug royalty rights for $3.3bn

Kalydeco pills and bottle

Source: Michael Dwyer / Alamy

‘Venture philanthropy’ model pays off with massive cash injection for charity

To continue reading this article

You need to sign in or choose one of these options

Subscribe

£36 annual | Pay monthly | Pass
Subscribers get unlimited access to Chemistry World. No more paywalls. Plus your subscription will help fund the charitable work of the Royal Society of Chemistry, supporting chemists worldwide.

Register

Free
You'll be able to read more articles each month before you see another paywall. Perfect if you're a light user or want to read more before deciding to subscribe. It takes less than a minute and it's completely free.

Membership

Included as a benefit
Members of the Royal Society of Chemistry have unlimited access to Chemistry World as a benefit of membership. Just sign in with your usual membership credentials. Not a member? Find out how to join.